Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Evofem Biosciences
company
About
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.
- 101 - 250
Details
- Last Funding Type
- Series C
- Last Funding Money Raised
- $8M
- Industries
- Biopharma,Health Care,Medical,Women's
- Founded date
- Jan 1, 2009
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products. The company's first commercial product, Phexxi®, is the first and only hormone-free, prescription vaginal gel approved in the United States to prevent pregnancy.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
2
$28.60M
Evofem Biosciences has raised a total of
$28.60M
in funding over 2 rounds. Their latest funding was raised on
Feb 12, 2014 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Feb 12, 2014 | Series C | $8M | 1 | — | — | Detail |
| Dec 19, 2012 | Series C | $20.60M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Evofem Biosciences is funded by 2 investors.
AKS Capital
and Numoda Capital Innovations
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
|
— | Series C |
Numoda Capital Innovations
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
